ClinicalTrials.Veeva
Menu

Find clinical trials for Glioblastoma (GBM) in Madrid, MD

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Glioblastoma
Glioma
Brain Cancer
Cancer
Recurrence
Astrocytoma
Gliosarcoma

Glioblastoma (GBM) trials near Madrid, MD, ESP:

EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma

Optune® together with maintenance TMZ and placebo in newly diagnosed Glioblastoma (GBM) patients. The primary objective of the stud...

Enrolling
Glioblastoma
Drug: Temozolomide
Drug: Placebo

Phase 3

NovoCure
NovoCure

Madrid, Spain and 55 other locations

and tolerability of these combinations in adult participants with glioblastoma (GBM). Arm B which was previously added to the proto...

Enrolling
Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
Astrocytoma, Grade III
Drug: Debio 0123
Drug: Temozolomide

Phase 1, Phase 2

Debiopharm
Debiopharm

Madrid, Spain and 16 other locations

are also impermeable to the passage of therapeutic molecules from the blood to the brain. The development of effective treatments against glioblastoma...

Enrolling
Glioblastoma
Recurrent Glioblastoma
Device: SonoCloud-9 (SC9)
Drug: Temozolomide

Phase 3

Carthera

Madrid, Spain and 47 other locations

A Dose Finding Study of \[177Lu\]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination with Standard of Care and in Recurrent Glioblastoma...

Enrolling
Glioblastoma
Drug: [68Ga]Ga-DOTA-TATE
Other: Temozolomide

Phase 1

Novartis
Novartis

Madrid, Spain and 14 other locations

(TMZ) in adult participants with newly-diagnosed, MGMT unmethylated glioblastoma multiforme (GBM). The main questions it aims to an...

Enrolling
Glioblastoma
GBM
Drug: Niraparib
Drug: Temozolomide

Phase 3

Ivy Brain Tumor Center

Madrid, Madrid, Spain and 62 other locations

This study will investigate different doses of \[177Lu\]Lu-NeoB in combination with RT and TMZ in participants with newly diagnosed glioblastoma...

Enrolling
Newly Diagnosed and Recurrent Glioblastoma
Other: Temozolomide
Drug: [68Ga]Ga-NeoB

Phase 1

Novartis
Novartis

Madrid, Spain and 22 other locations

The goal of this interventional study is to determine the strength of cobolimab and dostarlimab that is most tolerated in children and young adults w...

Active, not recruiting
Glioblastoma Multiforme (GBM)
Osteosarcoma
Drug: Dostarlimab
Drug: Cobolimab

Phase 1, Phase 2

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Madrid, Spain and 17 other locations

used as adjuvant treatment in patients with newly diagnosed GBM who are MGMT unmethylated and have completed concomitant treatment with temo...

Active, not recruiting
Glioblastoma Multiforme
Drug: Tinostamustine

Early Phase 1

Mundipharma
Mundipharma

Madrid, Spain and 4 other locations

This is an open-label, multicenter, randomized, parallel, 2-arm, efficacy and safety study. Patients with GBM after failure of standard firs...

Active, not recruiting
Glioblastoma Multiforme, Adult
Drug: Berubicin
Drug: Lomustine

Phase 2

CNS Pharmaceuticals
CNS Pharmaceuticals

Madrid, Spain and 47 other locations

The proposed Phase IIB/III randomized, double-blind, placebo-controlled trial in subjects with newly diagnosed primary glioblastoma multifor...

Active, not recruiting
Glioblastoma Multiforme
Primary Glioblastoma
Drug: TMZ
Drug: LAM561

Phase 2, Phase 3

Laminar Pharma

Madrid, Spain and 21 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems